Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Astrocytoma of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05879120
What this trial is testing

Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06640582
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+4 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT00005637
What this trial is testing

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04845919
What this trial is testing

Sonodynamic Therapy With ExAblate System in Glioblastoma Patients

Who this might be right for
Glioblastoma Multiforme
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 5
Testing effectiveness (Phase 2)Study completedNCT00486603
What this trial is testing

Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Testing effectiveness (Phase 2)Study completedNCT00029783
What this trial is testing

Efficacy of Distant Healing in Glioblastoma Treatment

Who this might be right for
Glioblastoma
National Center for Complementary and Integrative Health (NCCIH) 150
Testing effectiveness (Phase 2)Study completedNCT00293423
What this trial is testing

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 96
Early research (Phase 1)Ended earlyNCT04397679
What this trial is testing

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Barbara Ann Karmanos Cancer Institute 2
Early research (Phase 1)Study completedNCT02709226
What this trial is testing

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+1 more
National Cancer Institute (NCI) 17
Not applicableLooking for participantsNCT06146725
What this trial is testing

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Who this might be right for
GlioblastomaGlioblastoma, IDH-wildtypeGlioblastoma Multiforme+2 more
Jasper Gerritsen 564
Testing effectiveness (Phase 2)Study completedNCT00501891
What this trial is testing

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma Multiforme
Duke University 32
Testing effectiveness (Phase 2)Study completedNCT04743310
What this trial is testing

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Who this might be right for
Central Nervous System Tumor
John Yu 50
Not applicableEnded earlyNCT02905643
What this trial is testing

Discerning Pseudoprogression vs True Tumor Growth in GBMs

Who this might be right for
Glioblastoma
Ascension Health 1
Testing effectiveness (Phase 2)Study completedNCT00003616
What this trial is testing

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT00017147
What this trial is testing

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
SWOG Cancer Research Network 183
Very early researchEnded earlyNCT04825275
What this trial is testing

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 7
Large-scale testing (Phase 3)Active Not RecruitingNCT00978458
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System TumorsNeurotoxicity
Eastern Cooperative Oncology Group 540
Very early researchEnded earlyNCT04869449
What this trial is testing

Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 1
Early research (Phase 1)Study completedNCT01048008
What this trial is testing

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer

Who this might be right for
Advanced CancerBrain Involvement
DEKK-TEC, Inc. 22
Testing effectiveness (Phase 2)WithdrawnNCT01782976
What this trial is testing

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center
Next Page